Hepatitis B Clinical Trials Database - Free Access to 301 Studies
Access comprehensive clinical trial information for Hepatitis B through Pure Global AI's free database. This collection includes 301 clinical trials across multiple phases including N/A, Phase 3, Phase 4. Currently, 31 trials are actively recruiting participants.
Research for Hepatitis B is being conducted in China, United States of America, South Korea and 7+ other countries. Leading sponsors include GlaxoSmithKline and Gilead Sciences. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Assessment of Hepatitis B Vaccine Manufactured by a Modified Process in Healthy Neonates (babies 1 to 10 days old)
A Study to Evaluate the Relative Bioavailability of Subcutaneous Bepirovirsen When Delivered From a Vial or Prefilled Syringe Fitted With a Safety Syringe Device in Healthy Adult Participants
Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients
HBV Reactivation in Anti CD20 Treatment
A Study of AB-161 Following Oral Administration in Healthy Subjects
A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.
A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years
Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes
Prevalence of HBV in Pregnancy
Study of GSK3965193 in Healthy Participants and Alone and in Combination With Bepirovirsen in Participants Living With Chronic Hepatitis B Infection
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers
HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers
Untitled Trial
Untitled Trial
Evaluation of Hepatitis B Virus (HBV) DNA Test as Point of Care Tool
Long-term Follow-up Study to Evaluate Durability of Sustained Virologic Response (SVR) in Previous GSK3228836 Study Participants (B-Sure)
Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic Impairment
Real World Assessment of People Living With Chronic Hepatitis B in Australia
Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of DA-2803 in Healthy Subjects
Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 Tablets
Pure Global AI provides free access to 301 clinical trials studying Hepatitis B, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include GlaxoSmithKline, Gilead Sciences, Bukwang Pharmaceutical, among others.